
In the past few years, the global RNAi market has shown several promising developments, and is expected to evolve greatly from its current state. According to a new research report by RNCOS, the competitive landscape in the flourishing RNAi industry is highly fragmented, with companies like Alnylam, Isis, and Tekmira providing an extensive platform for RNAi-related research and development, and Bioneer Corporation, Dharmacon and Life Technologies selling diverse RNAi products, such as vectors, reagents, kits and services. It is anticipated that the global RNAi market will expand stupendously at a CAGR of around 17% during 2011-2015.